Postintervention and 3-month follow-up assessments were evaluated to determine the feasibility and effectiveness of GET in managing distress in young Latino men with testicular cancer.
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
There are several types of tic disorders with overlapping and distinct symptoms. Keep reading to learn the basics about their causes, triggers, and treatment options.
Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.